Patients and scientists join forces for rare disease progress, Arcturus Therapeutics asserts

Patients and scientists join forces for rare disease progress, Arcturus Therapeutics asserts
Arcturus advances rare disease efforts

Arcturus Therapeutics convened key players from translational biology, clinical development, and the patient community for Rare Disease Day.

The event aimed to create new momentum in collaboration and foster meaningful progress in the fight against rare diseases. Company representatives reaffirmed their commitment to listening to patient needs, symbolized by the well-known zebra motif in rare disease advocacy. The gathering underscored the growing importance of patient voices in shaping research and development strategies for the rare disease sector.

The event’s emphasis on patient engagement mirrors Arcturus Therapeutics’ ongoing efforts to align research priorities with community needs, a theme highlighted in the company’s recent financial results and pipeline progress report. As the sector looks ahead to major industry gatherings, including the forthcoming Leerink Partners 2026 Global Healthcare Conference, sustained collaboration and dialogue with patient advocates remain central to advancing mRNA and rare disease initiatives.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.